Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Barbara M. Foster"'
Autor:
Joanne F. Chou, Ann C. Mertens, Melissa M. Hudson, Stephanie M. Smith, Jennifer S. Ford, Emily S. Tonorezos, Kevin C. Oeffinger, Jacqueline Casillas, Barbara M. Foster, George R. Buchanan, Chaya S. Moskowitz, Leslie L. Robison
Publikováno v:
Cancer
Background Optimal risk-based survivor health care includes surveillance for late effects and education targeted at reducing or preventing risky health behaviors. Understanding the reasons for a lack of risk-based follow-up care is essential. Methods
Publikováno v:
Journal of Community Health. 39:83-89
Despite the growing body of health information available online, patients with limited health literacy may lack either internet access or skills necessary to utilize this information. Nonetheless, patients at all health literacy levels may prefer oth
Autor:
Brad Zebrack, Kelly L. Cotter, Debra A. Eshelman, Lauren Loftis, Melissa M. Hudson, Barbara M. Foster, Ann C. Mertens, Margaret S. Sozio, Kevin C. Oeffinger
Publikováno v:
Health Policy. 69:169-178
Objectives: To identify barriers to, models of care for, and initiatives to improve health care of adult survivors of childhood cancer. Methods: Seventeen health care policy experts were asked to respond to the three objectives through a three-iterat
Autor:
Gil I. Wolfe, John W. Day, Wilson W. Bryan, Charles A. Thornton, Sharon P. Nations, Gareth Parry, Carlayne E. Jackson, John T. Kissel, Barbara M. Foster, Miriam Freimer, Anthony A. Amato, Richard J. Barohn
Publikováno v:
Muscle & Nerve. 26:549-552
We initiated a randomized, double-blinded, placebo-controlled trial of intravenous immunoglobulin (IVIG) treatment in myasthenia gravis (MG). Patients received IVIG 2 gm/kg at induction and 1 gm/kg after 3 weeks vs. 5% albumin placebo. The primary ef
Autor:
Gail E. Tomlinson, Debra A. Eshelman, Barbara M. Foster, George R. Buchanan, Kevin C. Oeffinger
Publikováno v:
Cancer. 88:1687-1695
BACKGROUND The objective of the current study was to describe a multidisciplinary transition program for following young adult survivors of childhood cancer in an adult-based ambulatory medical setting and to report the late effects with grades of to
Autor:
Nora Gimpel, L. O'Neil, A. Marcee, James W. Walton, H. Kitzman-Ulrich, Mark J. DeHaven, Barbara M. Foster, D. Culica, Melanie M. Biggs
Publikováno v:
Journal of public health (Oxford, England). 34(4)
Approximately 19% of non-elderly adults are without health insurance. The uninsured frequently lack a source of primary care and are more likely to use the emergency department (ED) for routine care. Improving access to primary care for the uninsured
Publikováno v:
The American journal of managed care. 17(6 Spec)
To assess the feasibility and effectiveness of shared medical appointments (SMAs) among Hispanic patients with diabetes mellitus attending a family medicine residency clinic.Exploratory and descriptive study.Hispanic patients having diabetes with poo
Autor:
Zafreen Siddiqui, Barbara M. Foster, Emeka J Ohagi, Nora Gimpel, Tiffany M. Billmeier, Amer Shakil, Hina Rizvi
Publikováno v:
Journal of community health. 35(4)
We examined awareness of osteoporosis prevention among peri- and post-menopausal South Asian women attending two community centers in the Dallas/Fort-Worth Metroplex. We conducted a quasi-experimental study (final N = 61) assessing knowledge about os
Autor:
Linda S. Hynan, Barbara M. Foster
Publikováno v:
Teaching of Psychology. 24:52-54
This article describes a project used in a sophomore-level psychological testing and measurement course. The project helps integrate the seemingly separate topics of item writing, reliability, and validity by having students work through the differen
Autor:
George R. Buchanan, John A. Germak, Kevin C. Oeffinger, Gail E. Tomlinson, Laura E. Snell, Thomas C. Andrews, Debra A. Eshelman, Barbara M. Foster, Margo A. Denke
Publikováno v:
Journal of pediatric hematology/oncology. 23(7)
Purpose To assess cardiovascular risk factors (CVRF) in young adult survivors of childhood acute lymphoblastic leukemia (ALL). Patients and methods Twenty-six subjects (median age, 20.9 years; median interval since completion of therapy, 13.3 years)